科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/05/08 | 6,400 | 6,500 | 6,310 | 6,420 | +30 | +0.5% | 100,900 |
2018/05/07 | 6,310 | 6,390 | 6,310 | 6,390 | -70 | -1.1% | 81,500 |
2018/05/02 | 6,530 | 6,540 | 6,410 | 6,460 | -30 | -0.5% | 81,400 |
2018/05/01 | 6,480 | 6,500 | 6,430 | 6,490 | +10 | +0.2% | 50,100 |
2018/04/27 | 6,530 | 6,540 | 6,460 | 6,480 | ±0 | ±0% | 76,200 |
2018/04/26 | 6,510 | 6,540 | 6,450 | 6,480 | +20 | +0.3% | 72,500 |
2018/04/25 | 6,410 | 6,520 | 6,400 | 6,460 | +30 | +0.5% | 82,200 |
2018/04/24 | 6,330 | 6,430 | 6,330 | 6,430 | +50 | +0.8% | 73,200 |
2018/04/23 | 6,420 | 6,430 | 6,350 | 6,380 | -10 | -0.2% | 79,100 |
2018/04/20 | 6,370 | 6,440 | 6,370 | 6,390 | ±0 | ±0% | 73,500 |
2018/04/19 | 6,450 | 6,460 | 6,340 | 6,390 | -60 | -0.9% | 90,000 |
2018/04/18 | 6,430 | 6,480 | 6,420 | 6,450 | +40 | +0.6% | 73,200 |
2018/04/17 | 6,350 | 6,480 | 6,350 | 6,410 | -20 | -0.3% | 85,200 |
2018/04/16 | 6,270 | 6,440 | 6,260 | 6,430 | +160 | +2.6% | 100,300 |
2018/04/13 | 6,390 | 6,420 | 6,260 | 6,270 | -90 | -1.4% | 100,200 |
2018/04/12 | 6,360 | 6,430 | 6,340 | 6,360 | +10 | +0.2% | 81,300 |
2018/04/11 | 6,410 | 6,450 | 6,290 | 6,350 | -80 | -1.2% | 125,700 |
2018/04/10 | 6,430 | 6,550 | 6,410 | 6,430 | -70 | -1.1% | 132,400 |
2018/04/09 | 6,500 | 6,560 | 6,450 | 6,500 | +30 | +0.5% | 123,300 |
2018/04/06 | 6,400 | 6,500 | 6,350 | 6,470 | +50 | +0.8% | 147,700 |
2018/04/05 | 6,400 | 6,450 | 6,370 | 6,420 | +110 | +1.7% | 201,400 |
2018/04/04 | 6,300 | 6,320 | 6,230 | 6,310 | +40 | +0.6% | 99,300 |
2018/04/03 | 6,140 | 6,300 | 6,100 | 6,270 | +40 | +0.6% | 121,000 |
2018/04/02 | 6,300 | 6,300 | 6,220 | 6,230 | -50 | -0.8% | 92,400 |
2018/03/30 | 6,300 | 6,340 | 6,210 | 6,280 | +40 | +0.6% | 103,300 |
2018/03/29 | 6,280 | 6,310 | 6,160 | 6,240 | +10 | +0.2% | 108,200 |
2018/03/28 | 6,120 | 6,250 | 6,120 | 6,230 | -30 | -0.5% | 125,800 |
2018/03/27 | 6,140 | 6,270 | 6,140 | 6,260 | +190 | +3.1% | 193,200 |
2018/03/26 | 5,900 | 6,070 | 5,900 | 6,070 | +210 | +3.6% | 198,600 |
2018/03/23 | 6,010 | 6,050 | 5,850 | 5,860 | -250 | -4.1% | 123,300 |
2018/03/22 | 5,900 | 6,130 | 5,900 | 6,110 | +170 | +2.9% | 166,800 |
2018/03/20 | 5,960 | 5,960 | 5,900 | 5,940 | -50 | -0.8% | 80,300 |
2018/03/19 | 6,000 | 6,050 | 5,970 | 5,990 | -30 | -0.5% | 95,100 |
2018/03/16 | 6,070 | 6,130 | 6,010 | 6,020 | -120 | -2% | 146,100 |
2018/03/15 | 6,150 | 6,200 | 6,100 | 6,140 | -40 | -0.6% | 123,400 |
2018/03/14 | 6,180 | 6,220 | 6,140 | 6,180 | ±0 | ±0% | 105,400 |
2018/03/13 | 6,100 | 6,180 | 6,080 | 6,180 | +70 | +1.1% | 84,100 |
2018/03/12 | 6,120 | 6,190 | 6,050 | 6,110 | +90 | +1.5% | 119,100 |
2018/03/09 | 6,050 | 6,090 | 5,960 | 6,020 | +60 | +1% | 155,100 |
2018/03/08 | 5,960 | 5,980 | 5,930 | 5,960 | +60 | +1% | 81,200 |
2018/03/07 | 5,810 | 6,000 | 5,800 | 5,900 | +90 | +1.5% | 160,900 |
2018/03/06 | 5,860 | 5,910 | 5,790 | 5,810 | -50 | -0.9% | 150,100 |
2018/03/05 | 5,870 | 5,990 | 5,810 | 5,860 | -90 | -1.5% | 217,600 |
2018/03/02 | 6,000 | 6,080 | 5,920 | 5,950 | -140 | -2.3% | 174,200 |
2018/03/01 | 6,010 | 6,110 | 5,980 | 6,090 | +30 | +0.5% | 136,100 |
2018/02/28 | 5,980 | 6,110 | 5,950 | 6,060 | +60 | +1% | 182,600 |
2018/02/27 | 6,050 | 6,090 | 5,990 | 6,000 | -30 | -0.5% | 122,700 |
2018/02/26 | 5,990 | 6,080 | 5,970 | 6,030 | +40 | +0.7% | 123,300 |
2018/02/23 | 5,940 | 6,000 | 5,940 | 5,990 | +50 | +0.8% | 83,000 |
2018/02/22 | 6,010 | 6,010 | 5,920 | 5,940 | -130 | -2.1% | 107,700 |
1601~
1650
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
サワイGHD | 197,200円 | +4.0% | +25.4% | 2.69% | 9.11倍 | 1.20倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
住友ファーマ | 60,900円 | +7.5% | - | 0.00% | - | 2.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム